Emergence of SHV-12 extended spectrum beta-lactamase among clinical isolates of Enterobacter cloacae in Tunisia

Microbial Pathogenesis

Volumn 53, Issue 2, 2012, Pages 64-65

  Lahlaoui, Hella ^a   Anis, Ben Haj Khalifa ^b   Mohamed, Kheder ^b   Mohamed, Ben Moussa ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

^b Tahar Sfar University Hospital   (Tunisia)

Author keywords

BLSE; E. cloacae; SHV 12; Tunisia

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE SHV; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; IMIPENEM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; BETA LACTAMASE SHV 12 GENE; CONTROLLED STUDY; DNA FLANKING REGION; ENTEROBACTER CLOACAE; GENE TRANSFER; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SPECIES DIFFERENTIATION; TUNISIA;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; TUNISIA; YOUNG ADULT;

ENTEROBACTER CLOACAE;

EID: 84862756334     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2012.04.003     Document Type: Article

References (18)

1. Al Naiemi N., Zwart B., Rijnsburger M.C., Roosendaal R., Debets-Ossenkopp Y.J., Mulder J.A., et al. Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. J Clin Microbiol 2008, 46:2794-2795.
2. Kasap M., Fashae K., Torol S., Kolayli F., Budak F., Vahaboglu H. Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria. Ann Clin Microbiol Antimicrob 2010, 9:1.
3. al Naiemi N., Schipper K., Duim B., Bart A. Application of minimal sequence quality values prevents misidentification of the blaSHV type in single bacterial isolates carrying different SHV extended-spectrum β-lactamase genes. J Clin Microbiol 2006, 44:1896-1898.
4. Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14:933-951.
5. Szabó D., Bonomo R.A., Silveira F., Pasculle A.W., Baxter C., Linden P.K., et al. SHV-type extended-spectrum beta-lactamase production is associated with reduced cefepime susceptibility in Enterobacter cloacae. J Clin Microbiol 2005, 43:5058-5064.
6. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; 20th informational supple-ment M100-S20 2010, Clinical and Laboratory Standards Institute, Wayne, PA.
7. Sharma J., Sharma M., Ray P. Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J Med Res 2010, 132:332-336.
8. Lartigue M.F., Zinsius C., Wenger A., Bille J., Poirel L., Nordmann P. Extended-spectrum {beta}-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother 2007, 51:2855-2860.
9. Ambler R.P., Coulson A.F.W., Frère J.M., Ghuysen J.M., Joris B., Forsman M., et al. A standard numbering scheme for the class A β-lactamases. Biochem J 1991, 276:269-272.
10. SHV-2a in Korea. J Antimicrob Chemother 2002, 49:261-267.
11. Ryoo N.H., Kim E.C., Hong S.G., Park Y.J., Lee K., Bae I.K., et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005, 56:698-702.
12. Biendo M., Manoliu C., Laurans G., Castelain S., Canarelli B., Thomas D., et al. Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M beta-lactamases in clinical isolates of Enterobacter cloacae. Res Microbiol 2008, 159:590-594.
13. Nüesch-Inderbinen M.T., Kayser F.H., Hachler H. Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzer-land: two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother 1997, 41:943-949.
14. Kim J., Kwon Y., Pai H., Kim J.W., Cho D.T. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol 1998, 36:1446-1449.
15. Perilli M., Dell'Amico E., Segatore B., de Massis M.R., Bianchi C., Luzzaro F., et al. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 2002, 40:611-614.
16. Yan J.J., Wu S.M., Tsai S.H., Wu J.J., Su I.J. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother 2000, 44:1438-1442.
17. Ben-Hamouda T., Foulon T., Ben-Mahrez K. Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Tunisian neonatal ward. Microb Drug Resist 2004, 10:132-138.
18. Ford P.J., Avison M.B. Evolutionary mapping of the SHV beta-lactamase and evidence for two separate IS26-dependent blaSHV mobilization events from the Klebsiella pneumoniae chromosome. J Antimicrob Chemother 2004, 54:69-75.